Surface modification of biomaterials at the nanoscale: Biomimetic scaffolds for tissue engineering applications

Nanotechnology and Tissue Engineering: The Scaffold

Volumn , Issue , 2008, Pages 163-196

  Lee, Duron A ^a   Laurencin, Cato T ^b  

^a DREXEL UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84922827046     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (326)

1. Hersel U, Dahmen C, and Kessler H. 2003. RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 24:4385-4415.
2. Hubbell JA. 1995. Biomaterials in tissue engineering. Biotechnology 13:565-576.
3. Marler JJ, Upton J, Langer R, and Vacanti JP. 1998. Transplantation of cell in matrices for tissue engineering. Adv. Drug Deliv. Rev. 13:165-182.
4. Murphy WL and Mooney DJ. 1999. Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. J. Periodontal. Res. 34:413-419.
5. Ratner BD and Bryant SJ. 2004. Biomaterials: Where we have been and where are we going. Annu. Rev. Biomed. Eng. 6:41-75.
6. Lao HK, Renard E, Linossier I, Langlois V, and Vallée-Rehel K. 2007. Modification of poly(3-hydroxy butyrate-co-3-hydroxyvalerate) film by chemical graft copolymerization. Biomacromolecules 8:416-423.
7. Langer R. 2000. Biomaterials in drug delivery and tissue engineering: One laboratory’s experience. Acc. Chem. Res. 33:94-101.
8. Elbert DL and Hubbell JA. 1996. Surface treatments of polymers for biocompatibility. Annu. Rev. Mater. Sci. 26:365-394.
9. Ikada Y. 1994. Surface modification of polymers for medical applications. Biomaterials 15:725-736.
10. Drumheller PD, Herbert CB, and Hubbell JA. 1996. Bioactive peptides and surface design. Bioprocess. Technol. 23:273-310.
11. Lebaron RG and Athanasiou KA. 2000. Extracellular matrix cell adhesion peptides: Functional applications in orthopedic materials. Tissue Eng. 6:85-103.
12. Shakesheff KM, Cannizzaro SM, and Langer R. 1998. Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. J. Biomat. Sci. Polym. Ed. 9:507-518.
13. Hubbell JA. 1999. Bioactive biomaterials. Curr. Opin. Biotechnol. 10:123-129.
14. Mooney D, Hansen L, Vacanti J, Langer R, Farmer S, and Ingber D. 1992. Switching from differentiation to growth in hepatocytes: Control by extracellular matrix. J. Cell. Physiol. 151:497-505.
15. Blaschke RJ, Howlett AR, Desprez PY, Peterson OW, and Bissell MJ. 1994. Cell differentiation by extracellular matrix components. Methods Enzymol. 245:535-556.
16. Chen CS, Mrksich M, Huang S, Whitesides GM, and Ingber DE. 1997. Geometric control of cell life and death. Science 276:1425-1428.
17. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, and Derynck R. 1993. Extracellular matrix regulates expression of the TGF-beta 1 gene. J. Cell Biol. 120:253-260.
18. Lelievre SA, Weaver VM, Nickerson JA, Larabell CA, Bhaumik A, Petersen OW, et al. 1998. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proc. Nat. Acad. Sci. USA 95:14711-14716.
19. Masuko T, Iwasaki N, Yamane S, Funakoshi T, Majima T, Minami A, et al. 2005. Chitosan-RGDSGGC conjugate as a scaffold material for musculoskeletal tissue engineering. Biomaterials 26:5339-5347.
20. Hauschka SD and Konigsberg IR. 1966. The influence of collagen on the development of muscle colonies. Proc. Natl. Acad. Sci. USA 55:119-126.
21. Boudreau N, Myers C, and Bissell MJ. 1995. From lamini to lamin: Regulation of tissue-specific gene expression by the ECM. Trends Cell. Biol. 5:1-4.
22. Ingber D. 1991. Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J. Cell Biochem. 47:236-241.
23. Bissell MJ, Hall HG, and Parry G. 1982. How does the extracellular matrix direct gene expression? J. Theor. Biol. 99:31-68.
24. Borchiellini C, Coulon J, and Le Parco Y. 1996. The function of type IV collagen during drosophila muscle development. Mech. Dev. 58:179-191.
25. Murray MA, Fessler LI, and Palka J. 1995. Changing distributions of extracellular matrix components during early wing morphogenesis in Drosophila. Dev. Biol. 168:150-165.
26. Buck C and Horwitz AF. 1987. Cell surface receptors for extracellular matrix molecules. Annu. Rev. Cell Bio. 3:179-205.
27. Singer II, Scott S, Kawak DW, Kazazis DM, Gailit J, and Ruoslahti E. 1988. Cell surface distribution of fibronectin and vitronectin receptors depends on substrate composition and extracellular matrix accumulation. J. Cell Biol. 106:2171-2182.
28. Mosher DF. 1993. Assembly of fibronectin into extracellular matrix. Curr. Opin. Struct. Biol. 3:214-222.
29. Andeson JM. 2001. Biological responses to materials. Annu. Rev. Mater. Res. 31:81-110.
30. Shin H, Jo S, and Mikos AG. 2003. Biomimetic materials for tissue engineering. Biomaterials 24:4353-4364.
31. Ruoslahti E and Pierschbacher MD. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
32. Albelda SM and Buck CA. 1990. Integrins and other cell adhesion molecules. FASEB J. 4:2868-2880.
33. Travis J. 1993. Biotech gets a grip on cell adhesion. Science 260:906-908.
34. van der Flier A and Sonnenberg A. 2001. Function and interactions of integrins. Cell Tissue Res. 305:285-298.
35. Plow EF, Haas TA, Zhang L, Loftus J, and Smith JW. 2000. Ligand binding to integrins. J. Biol. Chem. 275:21785-21788.
36. van der Flier A and Sonnenberg A. 2001. Function and interactions of integrins. Cell Tissue Res. 305:285-298.
37. Hynes RO. 1992. Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
38. Gottschalk K-E, Adams PD, Brunger AT, and Kessler H. 2002. Transmembrane signal transduction of the aIIbb3 integrin. Protein Sci. 11:1800-1812.
39. Lebaron R. 2000. Biomaterials in drug delivery and tissue engineering. Tissue Eng. 6:85-103.
40. Zamir E and Geiger B. 2001. Molecular complexity and dynamics of cell-matrix adhesions. J. Cell Sci. 114:3583-3590.
41. Geiger B and Bershadsky A. 2001. Assembly and mechanosensory function of focal contacts. Curr. Opin. Cell Biol. 13:584-592.
42. Petit V and Thiery JP. 2000. Focal adhesions: Structure and dynamics. Biol. Cell 92:477-494.
43. Pande G. 2000. The role of membrane lipids in regulation of integrin functions. Curr. Opin. Cell Biol. 12:569-574.
44. Boudreau NJ and Jones PL. 1999. Extracellular matrix and integrin signalling: The shape of things to come. Biochem. J. 339:481-488.
45. Schwartz MA. 2001. Integrin signaling revisited. Trends Cell. Biol. 11:466-470.
46. Bilezikian JP, Raisz LG, and Rodan GA, (Eds.). 1996. In Principles of Bone Biology, p. 268. San Diego: Academic Press.
47. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson I, and Peterson L. 1994. Treatment of deep cartilage defects in the knee with autogenous chondrocyte transplantation. New Engl. J. Med. 331:889-895.
48. Bell E, Ivarsson B, and Merrill C. 1979. Production of tissue-like structure and contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc. Natl. Acad. Sci. USA. 76:1274-1278.
49. Hansbrough JF, Christine D, and Hansbrough WB. 1992. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin graft on excised burn wounds. J. Burn Care Rehabil. 13:519-529.
50. Lundborg G, Gelberman RH, Longo FM, Dowell HC, and Varon S. 1982. In vivo regeneration of cut nerves encased in silicone tubes. J. Neuropathol. Exp. Neurol. 41:412-422.
51. Langer R and Vacanti JP. 1993. Tissue Engr. Sci. 260:920-926.
52. Langer R. 1997. Tissue engineering: A new field and its challenges. Pharm. Res 14:840-841.
53. Vacanti CA and Bonassar LJ. 1999. An overview of tissue engineered bone. Clin. Orthop. Relat. Res. 367S:S375-S381.
54. Laurencin CT, Attawia MA, Lu LQ, Borden MD, Lu HH, Gorum WJ, et al. 2001. Poly(lactide-coglycolide)/ hydroxyapatite delivery of BMP-2-producing cells: A regional gene therapy approach to bone regeneration. Biomaterials 22:1271-1277.
55. Ibarra C, Koski JA, and Warren RF. 2000. Tissue engineering meniscus: Cells and matrix. Orthop. Clin. North Am. 31:411-418.
56. Cima LG, Vacanti JP, Vacanti C, Ingber D, Mooney D, and Langer R. 1991. Tissue engineering by cell transplantation using degradable polymer substrates. J. Biomech. Eng. 113:143-151.
57. MacArthur BD and Oreffo ROC. 2005. Bridging the gap. Nature 433:19.
58. Vacanti CA and Vacanti JP. 2000. The science of tissue engineering. Orthop. Clin. North Am. 31:351-356.
59. Musgrave DS, Fu FH, and Huard J. 2002. Gene therapy and tissue engineering in orthopaedic surgery. J. Am. Acad. Orthop. Surg. 10:6-15.
60. Fleming JE, Cornell CN, and Muschler GF. 2000. Bone cells and matrices in orthopedic tissue engineering. Orthop. Clin. North Am. 31:357-374.
61. Laurencin CT, Attawia MA, Elgendy HE, and Herbert KM. 1996. Tissue engineered bone-regeneration using degradable polymers: The formation of mineralized matrices. Bone 19:93S-99S.
62. Attawia MA, Herbert KM, and Laurencin CT. 1995. Osteoblast-like cell adherence and migration through 3-dimensional porous polymer matrices. Biochem. Biophys. Res. Commun. 213:639-644.
63. Langer R and Vacanti JP. 1993. Tissue engineering. Science 260:920-926.
64. Hubbell JA. 1995. Biomaterials in tissue engineering. Bio/Technology 13:565-576.
65. Lee KB, Yoon KR, Woo SI, and Choi IS. 2003. Surface modification of poly(glycolic acid) (PGA) for biomedical applications. J. Pharm. Sci. 92:933-937.
66. Black J. 1999. Biological Performance of Materials: Fundamentals of Biocompatibility. New York: Marcel Dekker, Inc.
67. Sakiyama-Elbert SE and Hubbell JA. 2001. Functional biomaterials: Design of novel biomaterials. Ann. Rev. Mater. Res. 31:183-201.
68. Hubbell JA. 1999. Bioactive biomaterials. Curr. Opin. Biotechnol. 10:123-129.
69. Healy KE. 1999. Molecular engineering of materials for bioreactivity. Curr. Opin. Solid State Mater. Sci. 4:381-387.
70. Hoffman AS. 1992. Molecular bioengineering of biomaterials in the 1990s and beyond: A growing liaison of polymers with molecular biology. Artificial Organs 16:43-49.
71. Healy KE, Rezania A, and Stile RA. 1999. Designing biomaterials to direct biological responses. Ann. NY Acad. Sci. 875:24-35.
72. Ripamonti U. 1996. Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17:31-35.
73. Shin H, Jo S, and Mikos AG. 2003. Biomimetic materials for tissue engineering. Biomaterials 24:4353-4364.
74. Li JM, Menconi MJ, Wheeler HB, Rohrer MJ, Klassen VA, Ansell JE, et al. 1992. Precoating expanded polytetrafluoroethylene grafts alters production of endothelial cell-derived thrombomodulators. J. Vasc. Surg. 15:1010-1017.
75. Song E, Yeon KS, Chun T, Byun HJ, and Lee YM. 2006. Collagen scaffolds derived from a marine source and their biocompatibility. Biomaterials 27:2951-2961.
76. DeLustro F, Dasch J, Keefe J, and Ellingsworth L. 1990. Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin. Orthop. Relat. Res. 263-279.
77. Schlosser M, Zippel R, Hoene A, Urban G, Ueberrueck T, Marusch F, et al. 2005. Antibody response to collagen after functional implantation of different polyester vascular prostheses in pigs. J. Biomed. Mater. Res. A 72:317-325.
78. Schwartzmann M. 2000. Use of collagen membranes for guided bone regeneration: A review. Implant. Dent. 9:63-66.
79. Elbert DL and Hubbell JA. 2001. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules 2:430-441.
80. Lhoest JB, Detrait E, van den Bosch, de Aguilar, and Bertrand P. 1998. Fibronectin adsorption, conformation, and orientation on polystyrene substrates studied by radiolabeling, XPS, and ToF SIMS.J. Biomed. Mater. Res. 41:95-103.
81. Hlady V and Buijs J. 1996. Protein adsorption on solid surfaces. Curr. Opin. Biotechnol. 7:72-77.
82. Underwood PA, Steele JG, and Dalton BA. 1993. Effects of polystyrene surface chemistry on the biological activity of solid phase fibronectin and vitronectin, analysed with monoclonal antibodies. J. Cell Sci. 104: 793-803.
83. Stivaktakis N, Nikou K, Panagi Z, Beletsi A, Leondiadis L, and Avgoustakis K. 2005. Immune responses in mice of beta-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J. Biomed. Mater. Res. A 73:332-338.
84. Ito Y, Kajihara M, and Imanishi Y. 1991. Materials for enhancing cell adhesion by immobilization of cell-adhesive peptide. J. Biomed. Mater. Res. 25:1325-1337.
85. Neff JA, Caldwell KD, and Tresco PA. 1998. A novel method for surface modification to promote cell attachment to hydrophobic substrates. J. Biomed. Mater. Res 40:511-519.
86. Boxus T, Touillaux R, Dive G, and Marchand-Brynaert J. 1998. Synthesis and evaluation of RGD peptidomimetics aimed at surface bioderivatization of polymer substrates. Bioorg. Med. Chem. 6:1577-1595.
87. Ruoslahti E. 2003. The RGD story. A personal account. Matrix Biol. 22:459-465.
88. LeBaron RG and Athanasiou KA. 2000. Extracellular matrix cell adhesion peptides: Functional applications in orthopaedic materials. Tissue Eng. 6:85-103.
89. Pierschbacher MD and Ruoslahti E. 1984. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature 309:30-33.
90. Ruoslahti E and Pierschbacher MD. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
91. Oosterom R, Ahmed TJ, Poulis JA, and Bersee HE. 2006. Adhesion performance of UHMWPE after different surface modification techniques. Med. Eng. Phys. 28:323-330.
92. Hoffmann K, Resch-Genger U, Mix R, and Friedrich JF. 2006. Fluorescence spectroscopic studies on plasma-chemically modified polymer surfaces with fluorophore-labeled functionalities. J. Fluoresc. 16:441-448.
93. Hubbell JA, Massia SP, and Drumheller PD. 1992. Surface-grafted cell-binding peptides in tissue engineering of the vascular graft. Ann. N.Y. Acad. Sci. 665:253-258.
94. Hubbell JA, Massia SP, Desai NP, and Drumheller PD. 1991. Endothelial cell-selective materials for tissue engineering in the vascular graft via a new receptor. Biotechnology 9:568-572.
95. Ranieri JP, Bellamkonda R, Bekos EJ, Vargo TG Jr, and Aebischer JAG. 1995. Neuronal cell attachment to fluorinated ethylene propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. II.J. Biomed. Mater. Res. 29:779-785.
96. Rezania A and Healy KE. 1999. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol. Prog. 15:19-32.
97. Bellamkonda R, Ranieri JP, and Aebischer P. 1995. Laminin oligopeptide derivatized agarose gels allow three dimensional neurite extension in vitro. J. Neurosci. Res. 41:501-509.
98. Schense JC, Bloch J, Aebischer P, and Hubbell JA. 2000. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nature Biotech. 18:415-419.
99. Drumheller PD and Hubbell JA. 1994. Polymer networks with grafted cell adhesion peptides for highly biospecific cell adhesive substrates. Anal. Biochem. 222:380-388.
100. Davis DH, Giannoulis CS, Johnson RW, and Desai TA. 2003. Immobilization of RGD to silicon surfaces for enhanced cell adhesion and proliferation. Biomaterials 23:4019-4027.
101. Whitaker MJ, Quirk RA, Howdle SM, and Shakesheff KM. 2001. Growth factor release from tissue engineering scaffolds. J. Pharm. Pharmacol. 53:1427-1437.
102. Babensee JE, McIntire LV, and Mikos AG. 2000. Growth factor delivery for tissue engineering. Pharm. Res. 17:497-504.
103. Richardson TP, Murphy WL, and Mooney DJ. 2001. Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy. Crit. Rev. Eukaryot. Gene Expr. 11:47-58.
104. Hoffman AS. 1992. Molecular bioengineering of biomaterials in the 1990s and beyond: A growing liaison of polymers with molecular biology. Artif. Organs 16: 43-49.
105. Kouvroukoglou S, Dee KC, Bizios R, McIntire LV, and Zygourakis K. 2000. Endothelial cell migration on surfaces modified with immobilized adhesive peptides. Biomaterials 21:1725-1733.
106. Drumheller PD, Elbert DL, and Hubbell JA. 1994. Multifunctional poly(ethylene glycol) semi-interpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting. Biotechnol. Bioeng. 43:772-780.
107. Yang, Roach HI, Clarke NMP, Howdle SM, Quirk HR, Shakesheff KM, et al. 2001. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 29:523-531.
108. Sanghvi AB, Miller KP, Belcher AM, and Schmidt CE. 2005. Biomaterials functionalization using a novel peptide that selectively binds to a conducting polymer. Nat. Mater. 4:496-502.
109. Neff JA, Tresco PA, and Caldwell KD. 1999. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 20:2377-2393.
110. Tweden KS, Harasaki H, Jones M, Blevitt JM, Craig WS, Pierschbacher M, et al. 1995. Accelerated healing of cardiovascular textiles promoted by an RGD peptide. J. Heart Valve Dis. 4:S90-S97.
111. Olivieri MP and Tweden KS. 1999. Human serum albumin and fibrinogen interactions with an adsorbed RGD-containing peptide. J. Biomed. Mater. Res. 46:355-359.
112. Reyes CD and Garcia AJ. 2004. a2b1 integrin-specific collagen-mimetic surface supporting osteoblastic differentiation. J. Biomed. Mater. Res. 69A:591-600.
113. Reyes CD, Petrie TA, Burns KL, Schwartz Z, and Garcia AJ. 2007. Biomolecular surface coating to enhance orthopaedic tissue healing and integration. Biomaterials 28:3228-3135.
114. Reyes CD and Garcia AJ. 2003. Engineering integrin-specific surface with triple helical collagen-mimetic peptide. J. Biomed. Mater. Res. 65A:511-523.
115. Quirk RA, Davies MC, Tendler SJB, and Shakesheff KM. 2000. Surface engineering of poly(lactic acid) by entrapment of modifying species. Macromolecules 33:158-260.
116. Quirk RA, Chan WC, Davies MC, Tendler SJB, and Shakesheff KM. 2001. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials 22: 865-872.
117. Elbert DL and Hubbell JA. 1998. Self-assembly and steric stabilization at heterogeneous, biological surfaces using adsorbing block copolymers. Chem. Biol. 5:177-183.
118. Faraasen S, Vörös J, Csúcs, Textor M, Merkle HP, and Walter E. 2003. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm. Res. 20:237-245.
119. Hirano Y, Okuno M, Hayashi T, Goto K, and Nakajima A. 1993. Cell attachment activities of surface immobilized oligopeptides RGD, RGDS, RGDV, RGDT, and YIGSR toward five cell lines. J. Biomater. Sci. Polym. Ed. 4:235-243.
120. Cha T, Guo A, Jun Y, and Zhu XY. 2004. Immobilization of oriented protein molecules on poly(ethylene glycol)-coated Si(111). Proteomics 4:1965-1976.
121. Pelham RJ and Wang YL. 1998. Cell locomotion and focal adhesions are regulated by the mechanical properties of the substrate. Biol. Bull. 194:348-350.
122. Castel S, Pagan R, Mitjans F, Piulats J, Goodman S, Jonczyk A, et al. 2001. RGD peptides and monoclonal antibodies, antagonists of avb3-integrin, enter the cells by independent endocytic pathways. Lab. Invest. 81:1615-1626.
123. Awenat KM, Davis PJ, Moloney MG, and Ebenezer W. 2005. A chemical method for the convenient surface functionalisation of polymers. Chem. Commun. 8:990-992.
124. Katz E, Schlereth DD, and Schmidt HL. 1994. Electrochemical study of pyrrolquinoline quinone covalently immobilized as monolayer onto a cystamine modified gold electrode. J. Electroanal. Chem. 367:59-70.
125. Jennissen HP. 1995. Cyanogen bromide and tresyl chloride chemistry revisited: The special reactivity of agarose as a chromatographic and biomaterial support for immobilizing novel chemical groups. J. Mol. Recognit. 8:116-124.
126. Banerjee P, Irvine DJ, Mayes AM, and Griffith LG. 2000. Polymer latexes for cell-resistant and cellinteractive surface. J. Biomed. Mater. Res. 50:331-339.
127. Tong YW and Shoichet MS. 1998. Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons. J. Biomed. Mater. Res. 42:85-95.
128. Massia SP and Hubbell JA. 1991. Human endothelial cell interactions with surface-coupled adhesion peptides on a nonadhesive glass substrate and two polymeric biomaterials. J. Biomed. Mater. Res. 25:223-242.
129. Massia SP and Hubbell JA. 1990. Covalently attached GRGD on polymer surfaces promotes biospecific adhesion of mammalian cells. Ann. NY Acad. Sci. 589:261-270.
130. Nilsson K and Mosbach K. 1981. Immobilization of enzymes and affinity ligands to various hydroxyl groups carrying supports using highly reactive sulfonyl chlorides. Biochem. Biophys. Res. Comm. 102:449-457.
131. Nilsson K and Mosbach K. 1987. Tresyl chloride-activated supports for enzyme immobilization. Methods Enzymol. 135:65-78.
132. Nilsson K and Mosbach K. 1984. Immobilization of ligands with organic sulfonyl chlorides. Methods Enzymol. 104:56-69.
133. Hayakwa T, Yoshinar M, and Nemoto K. 2003. Direct attachment of fibronectin to tresyl chlorideactivated titanium. J. Biomed. Mater. Res 67A:684-688.
134. Hayakawa T, Yoshinari M, Nagai M, Yamamoto M, and Nemoto K. 2003. X-ray photoelectron spectroscopic studies of the reactivity of basic terminal OH of titanium towards tresyl chloride and fibronectin. Biomed. Res. 24:223-230.
135. Hayakwa T, Yoshinar M, and Nemoto K. 2005. Quartz-crystal microbalance-dissipation technique for the study of initial adsorption of fibronectin onto tresyl chloride-activated titanium. J. Biomed. Mater. Res. Part B: Appl. Biomater. 73B:271-276.
136. Tzorisa A, Hall EAH, Besselinkb GAJ, and Bergveld P. 2003. Testing the durability of polymyxin B immobilization on a polymer showing antimicrobial activity: A novel approach with the ion-step method. Analytical Letters 36:1781-1803.
137. Jo S, Shin H, and Mikos AG. 2001. Modification of oligo(poly(ethylene glycol) fumarate) macromere with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules 2:255-261.
138. Li JT, Carlsson J, Lin JN, and Caldwell KD. 1996. Chemical modification of surface active poly(ethylene oxide)-poly(propylene oxide) triblock copolymers. Bioconjug. Chem. 7:592-599.
139. Woerly S, Laroche G, Marchand R, Pato J, Subr V, and Ulbrich K. 1995. Intracerebral implantation of hydrogel-coupled adhesion peptides: Tissue reaction. J. Neural Transplant Plast. 5:245-255.
140. Morpurgo M, Bayer EA, and Wilchek M. 1999. N-hydroxysuccinimide carbonates and carbamates are useful reactive reagents for coupling ligands to lysines on proteins. J. Biochem. Biophys.Methods 38:17-28.
141. Benters R, Niemeyer NM, and Whorle D. 2001. Dendrimer-activated solid supports for nucleic acid and protein microarrays. ChemBiochem. 2:686-694.
142. Ynag M, Kong RYC, Kazmi N, and Leung AKC. 1994. Covalent immobilization of oligonucleotides on modified glass/silicon surfaces for solid-phase DNA hybridization and amplification. Chem. Lett. 27:257-258.
143. Pack SP, Kamisetty NK, Nonogawa M, Devarayapalli KC, Ohtani K, Yamada K, et al. 2007. Direct immobilization of DNA oligomers onto the amine-functionalized glass surface for DNA microarray fabrication through the activation-free reaction of oxanine. Nucleic Acids Res. 35:e110.
144. Kondoh A, Makino K, and Matsuda T. 1993. 2-Dimensional artificial extracellular-matrix-boadhesive peptide-immobilized surface design. J. Appl. Polym. Sci. 47:1983-1988.
145. Kim MR, Jeong JH, and Park TG. 2002. Swelling induced detachment of chondrocytes using RGDmodified poly(N-isopropylacryl-amide) hydrogel beads. Biotechnol. Prog. 18:495-500.
146. Carlisle ES, Mariappan MR, Nelson KD, Thomes BE, Timmons RB, Constantinescu A, et al. 2000. Enhancing hepatocyte adhesion by pulsed plasma deposition and poly-ethylene glycol coupling. Tissue Eng. 6:45-52.
147. Matsuya T, Tashiro S, Hoshino N, Shibata N, Nagasaki Y, and Kataoka K. 2003. A core-shell-type fluorescent nanosphere possessing reactive poly(ethylene glycol) tethered chains on the surface for zeptomole detection of protein in time-resolved fluorometric immunoassay. Anal. Chem. 75:6124-6132.
148. Tam JP, Yu Q, and Miao Z. 1999. Orthogonal ligation strategies for peptide and 154. protein. Biopolymers 51:311-332.
149. Camarero JA, Kwon Y, and Coleman MA. 2004. Chemoselective attachment of biologically active proteins to surfaces by expressed protein ligation and its application for '‘protein chip’’ fabrication. J. Am. Chem. Soc. 126:14730-14731.
150. Thumshirn G, Hersel U, Goodman SL, and Kessler H. 2003. Multimeric cyclic RGD peptides for tumor targeting: Solid-phase peptide synthesis and chemoselective oxime ligation. Chemistry 9:2717-2725.
151. Scheibler L, Dumy P, Boncheva M, Leufgen K, Mathieu H-J, Mutter M, et al. 1999. Functional molecular thin films: Topological templates for the chemoselective ligation of antigenic peptides to self-assembled monolayers. Angew. Chem. Int. Ed. 38:696-699.
152. Bourel-Bonnet L, Pécheur E-I, Grandjean C, Blanpain A, Baust T, Melnyk O, et al. 2005. Anchorage of synthetic peptides onto liposomes via hydrazone and r-oxo hydrazone bonds. Preliminary functional investigations. Bioconjug. Chem. 16:450-457.
153. Dubs P, Bourel-Bonnet L, Subra G, Blanpain A, Melnyk O, Pinel A-M, et al. 2007. Parallel synthesis of a lipopeptide library by hydrazone-based chemical ligation. J. Combinatorial Chem. 9:973-981.
154. Ivanov B, Grzesik W, and Robey FA. 1995. Synthesis and use of a new bromoacetyl-derivatized heterotrifunctional amino acid for conjugation of cyclic RGD-containing peptides derived from human bone sialoprotein. Bioconj. Chem. 6:269-277.
155. Fields GB, Lauer JL, Dori Y, Forns P, Yu y-C, and Tirrell M. 1998. Proteinline molecular architecture: Biomaterial applications for inducing cellular receptor binding and signal transduction. Biopolymers 47:143-151.
156. Houseman BT, Gawalt ES, and Mrksich M. 2003. Maleimide functionalized self-assembled monolayers for the preparation of peptide and carbohydrate biochips. Langmuir 19:1522-1531.
157. Lateef SS, Boateng S, Hartman TJ, Crot CA, Russell B, and Hanley L. 2002. GRGDSP peptide-bound silicone membranes withstand mechanical flexing in vivo and display enhanced fibroblast adhesion. Biomaterials 23:3159-3168.
158. Herbert CB, McLernon TL, Hypolite CL, Adams DN, Pikus L, Huang CC, et al. 1997. Micropatterning gradients and controlling surface densities of photoactivatable biomolecules on self-assembled monolayers of oligo(ethylene glycol) alkanethiolates. Chem. Biol. 4:731-737.
159. Lin YS, Wang SS, Chung TW, Wang YH, Chiou SH, Hsu JJ, et al. 2001. Growth of endothelial cells on different concentrations of Gly-Arg-Gly-Asp photochemically grafted in polyethylene glycol modified polyurethane. Artif. Organs 25:617-621.
160. Sugawara T and Matsuda T. 1995. Photochemical surface derivatization of a peptide containing Arg-Gly Asp (RGD). J. Biomed. Mater. Res. 29:1047-1052.
161. Chung T-Z, Lu Y-F, Wang H-Y, Chen W-P, Wang S-S, Lin Y-S, et al. 2003. Growth of human endothelial cells on different concentrations of Gly-Arg-Gly-Asp grafted chitosan surface. Artificial Organs 27:155-161.
162. Massia SP and Hubbell JA. 1992. Binding domains for cell surface proteoglycan-mediated adhesion. J. Biol. Chem. 267:10133-10141.
163. Lee K-B, Yoon KR, Woo SI, and Choi IS. 2003. Surface modification of poly(glycolic acid) for biomedical applications. J. Pharm. Sci. 92:933-937.
164. Chen R, Curran SJ, Curran JM, and Hunt JA. 2006. The use of poly(L-lactide) and RGD modified microspheres as cell carriers in a flow intermittency bioreactor for tissue engineering cartilage. Biomaterials 27:4453-4460.
165. Zhu Y, Gao C, Liu X, and Shen J. 2002. Surface modification of polycaprolactone membrane via aminolysis and biomacromolecules immobilization for promoting cytocompatibility of human endothelial cells. Biomacromolecules 3:1312-1319.
166. Santiage LY, Nowak RW, Rubin PJ, and Marra KG. 2006. Peptide-surface modification of poly (caprolactone) with laminin-derived sequences for adipose-derived stem cell applications. Biomaterials 27:2962-2969.
167. Tong YW and Shoichet MS. 1998. Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons. J. Biomed. Mater. Res. 42:85-95.
168. Li J, Yun H, Gong Y, Zhao N, and Zhang X. 2006. Investigation of MC3T3-E1 cell behavior on the surface of GRGDS-coupled chitosan. Biomacromolecules 7:1112-1123.
169. Matsuzawa M, Liesi P, and Knoll W. 1996. Chemically modifying glass surfaces to study substratumguided neurite outgrowth in culture. J. Neurosci. Methods 69:189-196.
170. Mann BK, Tsai AT, Scott-Burden T, and West JL. 1999. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials 20:2281-2286.
171. Mann BK and West JL. 2002. Cell adhesion peptides alter smooth muscle adhesion, proliferation, migration and matrix protein synthesis on modified surfaces and in polymer scaffolds. J. Biomed. Mater. Res. 60:86-93.
172. Ren D, Hou S, Wang H, Luo D, and Zhang L. 2006. Evaluation of RGD modification on collagen matrix. Artif. Cells. Blood Substitutes Blood Technol. Biotechnol 34:293-303.
173. McGrath MP, Sall ED, and Tremont SJ. 1995. Functionalization of polymers by metal-mediated processes Chem. Rev. 95:381-398.
174. Crist GT and Millan MJ. 1998. Conjugate addition of amino acid side chains to dyes containing alkynone, alkynoic ester and alkynoic amide linker arms. Tetrahedron 54:649-666.
175. Wan YQ, Qu X, Lu J, Zhu CF, Wan LJ, Yang JL, Bei J, and Wang S. 2004. Characterization of surface properties of poly(lactide-co-glycolide) after oxygen plasma treatment. Biomaterials 25:4777-4783.
176. Kim KS, Lee KH, Cho K, and Park CE. 2002. Surface modification of polysulfone ultrafiltration membrane by oxygen plasma treatment. J. Membrane Sci. 135-145.
177. Shen H, Hu X, Yang F, Bei J, and Wang S. 2007. Combining oxygen plasma treatment with anchorage of cationized gelatin for enhancing cell affinity of poly(lactide-co-glucolide). Biomaterials 28:4219-4230.
178. Hu Y, Shelley WR, Krajbich I, and Hollinger JO. 2002. Porous polymer scaffolds surface-modified with arginine-glycine-aspartic acid enhance bone cell attachment and differentiation in vitro. J. Biomed. Mater. Res. 64A:583-590.
179. Shaw D and Shoichet MS. 2003. Torard sponal cord injury repair strategies: Peptide surface modification of expanded poly(tetrafluoroethylene) fibers for guided neurite outgrowth in vitro. J. Craniofac Sur. 14:308-316.
180. Guan JJ, Sacks MS, Beckman EJ, and Wagner WRJ. 2002. Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine J. Biomed. Mater. Res. 61:493-503.
181. Hrkach J, Ou J, Lotan N, and Langer R. 1999. Poly(L-lactic acid-co-amino acid) graft copolymers. J. Mater. Sci. Res. 78:92-102.
182. Shakesheff K, Cannizzaro S, and Langer R. 1998. Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. J. Biomater. Sci. Polym. Ed. 9:507-518.
183. Quirk RA, Davies MC, Tendler SJB, and Shekesheff KM. 2000. Surface engineering of poly(lactic acid) by entrapment of modifying species. Macromolecules 33:158-260.
184. Quirk RA, Chan WC, Davies MC, Tendler SJB, and Shekesheff KM. 2001. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials 22:865-872.
185. Cannizzaro SM, Padera RF, Langer R, Rogers RA, Black FE, Davies MC, et al. 1998. A novel biotinylated degradable polymer for cell-interactive applications. Biotechnol. Bioeng. 58:529-535.
186. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, and Dennis JW. 1996. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. J. Biol. Chem. 271:12755-12761.
187. Cook AD, Pajvani UB, Hrkach JS, Cannizzaro Sm, and Langer R. 1997. Colorimetric analysis of surface reactive amino groups on poly(lactic acid-co-lysine):poly(lactic acid) blends. Biomaterials 18:1417-1424.
188. Kubies D, Rypacek F, Kovarova J, and Lednicky F. 2000. Microdomain structure in polylactode-blockpoly(ethylene oxide) copolymer films. Biomaterials 21:529:36.
189. Elbert DL and Hubbell JA. 1996. Surface treatments of polymers for biocompatibility. Annu. Rev. Mater. Sci. 26:365-394.
190. Yosomiya R, Morimoto K, Nakajima A, Ikada Y, and Suzuki T., (Eds.). 1990. Surface modification of matrix polymer for adhesion. In Adhesion and Bonding in Composites. 83-100. New York: Marcel Dekker, Inc.
191. Candan S. 2002. Radio frequency-induced plasma polymerization of allyl alcohol and 1-propanol. Turk J. Chem. 26:783-791.
192. Hamerli P, Weigel T, Groth T, and Paul D. 2003. Surface properties of and cell adhesion onto allylamineplasma-coated polyethylenterephtalat membranes. Biomaterials 24:3989-3999.
193. Harsch A, Calderon JG, Timmons RB, and Gross GW. 2000. Pulsed plasma deposition of allylamine on polysiloxane: A stable surface for neuronal cell adhesion. J. Neurosci. Meth. 98:135-144.
194. Whittle JD, Short RD, Douglas CWI, and Davies J. 2000. Differences in the aging of allyl alcohol, acrylic acid, allylamine, and octa-1,7-diene plasma polymers as studied by x-ray photoelectron spectroscopy. Chem. Mater. 12:2664-2671.
195. Tarducci C, Schofield WCE, Badyal JPS, Brewer SA, and Willis C. 2001. Cyano-functionalized solid surfaces. Chem. Mater. 13:1800-1803.
196. Butoi CI, Mackie NM, Gamble LJ, Castner DG, Barnd J, Miller AM, et al. 2000. Deposition of highly ordered cf2-rich films using continuous wave and pulsed hexafluoropropylene oxide plasmas. Chem. Mater. 12:2014-2024.
197. Kelly JM, Short RD, and Alexander MR. 2003. Experimental evidence of a relationship between monomer plasma residence time and carboxyl group retention in acrylic acid plasma polymers. Polymer 44:3173-3176.
198. Watkins L, Bismarck A, Lee AF, Wilson D, and Wilson K. 2006. An XPS study of pulsed plasma polymerised allyl alcohol film growth on polyurethane. Appl. Surf. Sci. 252(23):8203-8211.
199. Ivanov VB, Behnisch J, Hollander A, Mehdorn F, and Zimmermann H. 1996. Determination of functional groups on polymer surfaces using fluorescence labeling. Surf. Interface Anal 24:257-262.
200. Davies J, Nunnerley CS, Brisley AC, Sunderland RF, Edwards JC, Kruger P, Kaes R, Paul AJ, and Hibbert S. 2000. Argon plasma treatment of polystyrene microtiter wells. Chemical and physical characterization by contact angle, ToF-SIMS, XPS and STM. Colloid Surf A 174:287-295.
201. Poncin-Epaillard F and Legeay G. 2003. Surface engineering of biomaterials with plasma techniques. J. Biomater. Sci. Polym. Edn. 14:1005-1028.
202. Nakaoka R, Tsuchiya T, and Nakamura A. 2003. Neural differentiation of midbrain cells on various protein-immobilized polyethylene films. J. Biomed. Mater. Res. 64A:439-446.
203. Thapa A, Webster J, and Haberstroh KM. 2003. Polymers with nanodimensioned surface features enhance bladders smooth muscle cell adhesion. J. Biomed. Mater. Res. 67A:1374-1383.
204. Chung TW, Lu YF, Wang SS, Lin YS, and Chu SH. 2002. Growth of human endothelial cells on photochemically grafted Gly-Arg-Gly-Asp (GRGD) chitosans. Biomaterials 23:4803-4809.
205. Calvert JW, Marra KG, Cook L, Kumta PN, DiMilla, and Weiss LE. 2000. Characterization of osteoblast-like behavior of culture bone marrow stromal cells on various polymer surfaces. J. Biomed. Mater. Res. 279-284.
206. DeGliglio E, Stefania C, Clavano C-D, Sabbatini L, Zambinin PG, Colucci S, et al. 2006. A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: Proliferation of osteoblast-like cells and future perspectives. J. Mater. Sci. Mater. Med. 18:1781-1789.
207. Chung T-W, Yang M-G, Liu D-Z, Chen W-P, Pan C-I, and Wang S-S. 2005. Enhancing growth human endothelial cells on Arg-Gly-Asp (RGD) embedded poly(e-caprolactone) (PCL) surface with nanometer scale of surface disturbance. J. Biomed. Mater. Res. 72A:213-219.
208. Patel S, Thkar RG, Wong J, McLeod SD, and Li S. 2006. Control of cell adhesion on poly(methyl methacrylate). Biomaterials 27:2890-2897.
209. Chung TW, Lu YF, Wang HY, Chen WP, Wang SS, Lin YS, et al. 2003. Growth of human endothelial cells on different concentrations of Gly-Arg-Gly-Asp grafted chitosan surface. Artif. Organs 27:155-161.
210. Konig U, Nitschke M, Pilz M, Simon F, Arnhold C, and Werner C. 2002. Stability and ageing of plasma treated poly(tetrafluoroethylene) surfaces. Colloid Surf. B-Biointerf 25:213-224.
211. Humphries MJ, Akiyama SK, Komoriya A, Olden K, and Yamada KM. 1986. Identification of an alternatively spliced site in human plasma fibronectin that mediates cell type-specific adhesion. J. Cell Biol. 103:2637-2647.
212. Underwood PA and Bennett FA. 1989. A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J. Cell Sci. 93:641-649.
213. Kantlehner M, Schaffner P, Finsinger D, Meyer J, Jonczyk A, Diefenbach B, et al. 2000. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 1:107-114.
214. Jeschke B, Meyer J, Jonczyk A, Kessler H, Adamietz P, Meenen NM, et al. 2002. RGD-peptides for tissue engineering of articular cartilage. Biomaterials 23:3455-3463.
215. Danilov YN and Juliano RL. 1989. (Arg-Gly-Asp)n-albumin conjugates as a model substratum for integrin-mediated cell adhesion. Exp. Cell Res. 182:186-196.
216. Hern DL and Hubbell JA. 1998. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 39:266-276.
217. Drumheller PD and Hubbell JA. 1994. Polymer networks with grafted cell adhesion peptides for highly biospecific cell adhesive substrates. Anal. Biochem. 222:380-388.
218. Massia SP and Hubbell JA. 1991. An RGD spacing of 440 nm is sufficient for integrin aVb3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J. Cell Biol. 114:1089-1100.
219. Drumheller PD, Elbert DL, and Hubbell JA. 1994. Multifunctional poly(ethylene glycol) semi-interpenetrating polymer networks as highly selective adhesive substrates for bioadhesive peptide grafting. Biotechnol. Bioeng. 43:772-780.
220. Neff JA, Tresco PA, and Caldwell KD. 1999. Surface modification for controlled studies of cell-ligand interactions. Biomaterials 20:2377-2393.
221. Palecek SP, Loftus JC, Ginsberg MH, Luffenburger DA, and Horwitz AF. 1997. Integrin-ligand binding properties govern cell migration speed through cell-substratum adhesiveness. Nature 385:537-540.
222. Irvine DJ, Hue KA, Mayes AM, and Griffith LG. 2002. Simulations of cell-surface integrin binding to nanoscale-clustered adhesion ligands. Biophys. J. 82:120-132.
223. Maheshwari G, Brown G, Lauffenburger DA, Wells A, and Griffith LG. 2000. Cell adhesion and motility depend on nanoscale RGD clustering. J. Cell Sci. 113:1677-1686.
224. Craig WS, Cheng S, Mullen DG, Blevitt J, and Pierschbacher MD. 1995. Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers 37:157-175.
225. Beer JH, Springer KT, and Coller BS. 1992. Immobilized Arg-Gly Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79:117-128.
226. Hern DL and Hubbell JA. 1998. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 39:266-276.
227. Shin H, Jo S, and Mikos AG. 2002. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo(poly(ethylene glycol) fumarate) hydrogels modified with Arg-Gly-Asp peptides and a poly(ethylene glycol) spacer. J. Biomed. Mater. Res. 61:169-179.
228. Loebsack A, Greene K, Wyatt S, Culberson C, Austin C, Beiler R, et al. 2001. In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J. Biomed. Mater. Res. 57:575-581.
229. Sakiyama-Elbert SE, Panitch A, Hubbell JA. 2001. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 15:1300-1302.
230. Hern DL and Hubbell JA. 1998. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 39:266-276.
231. Beer HJ, Springer KT, and Coller BS. 1992. Immobilized Arg-Gly-Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79:117-128.
232. Craig WS, Cheng S, Mullen DG, Blevitt J, and Pierschbacher MD. 1995. Concept and progress in the development of RGD-containing peptide pharmaceuticals. Biopolymers 37:157-175.
233. Elbert DL and Hubbell JA. 2001. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules 2:430-441.
234. Pelham RJ Jr, and Wang YL. 1998. Cell locomotion and focal adhesions are regulated by the mechanical properties of the substrate. Biol. Bull. 194:348-350.
235. Mammen M, Choi S-K, and Whitesides GM. 1998. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37:2755-2794.
236. Wong JY, Kuhl TL, Israelachvili JN, Mullah N, and Zalipsky S. 1997. Direct measurement of a tethered ligand-receptor interaction potential. Science 275:820-822.
237. Lo CM, Wang HB, Dembo M, and Wang YL. 2000. Cell movement is guided by the rigidity of the substrate. Biophys. J. 79:144-152.
238. Ruoslahti E. 2003. The RGD story. A personal account. Matrix Biol. 22:459-465.
239. Hirano Y, Okuno M, Hayashi T, Goto K, and Nakajima A. 1993. Cell-attachment activities of surface immobilized oligopeptides RGD, RGDS, RGDV, RGDT, and YIGSR toward five cell lines. J. Biomater. Sci. Polym. Ed. 4:235-243.
240. Delforge D, Gillon B, Art M, Dewelle J, Raes M, and Remacle J. 1998. Design of a synthetic adhesion protein by grafting RGD tailed cyclic peptides on bovine serum albumin. Lett. Pept. Sci. 5:87-91.
241. van der Pluijm G, Vloedgraven HJ, Ivanov B, Robey FA, Grzesik WJ, Robey PG, et al. 1996. Bone sialoprotein peptides are potent inhibitors of breast cancer cell adhesion to bone. Cancer Res. 56:1948-1955.
242. Pfaff M, Tangemann K, Muller B, Gurrath M, Muller G, Kessler H, et al. 1994. Selective recognition of cyclic RGD peptides of NMR defined conformation by aIIbb3, avb3, and a5b1 integrins. J. Biol. Chem. 269:20233-20238.
243. Pierschbacher MD and Ruoslahti E. 1987. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 262:17294-17298.
244. Dechantsreiter MA, Planker E, Mathä B, Lohof E, Hölzemann G, Jonczyk A, et al. 1999. N-methylated cyclic RGD peptides as highly active and selective avb3 integrin antagonists. J. Med. Chem. 42:3033-3040.
245. Kao WJ and Hubbell JA. 1998. Murine macrophage behavior on peptide-grafted polyethyleneglycolcontaining networks. Biotechnol. Bioeng. 59:2-9.
246. Pierschbacher MD and Ruoslahti E. 1987. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J. Biol. Chem. 262:17294-17298.
247. Kao WJ, Hubbell JA, and Anderson JM. 1999. Protein-mediated macrophage adhesion and activation on biomaterials: A model for modulating cell behavior. J. Mater. Sci. Mater. Med. 10:601-605.
248. Lin HB, Sun W, Mosher DF, Garciaecheverria C, Schaufelberger K, Lelkes PI, et al. 1994. Synthesis, surface, and cell adhesion properties of polyurethanes containing covalently grafted RGD-peptides. J. Biomed. Mater. Res. 28:329-342.
249. Beer JH, Springer KT, and Coller BS. 1992. Immobilized Arg-Gly Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79:117-128.
250. Lin HB, Garciaecheverria C, Asakura S, Sun W, Mosher DF, and Cooper SL. 1992. Endothelial-cell adhesion on polyurethanes containing covalently attached RGD-peptides. Biomaterials 13:905-914.
251. Rezania A and Healy KE. 1999. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J. Orthop. Res. 17:615-623; Cell Res. 182:186-196.
252. Massia SP and Stark J. 2001. Immobilized RGD peptides on surface grafted dextran promotes biospecific cell attachment. J. Biomed. Mater. Res. 56:390-399.
253. Sayers RD, Raptis S, Berce M, and Miller JH. 1998. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br. J. Surg. 85:934-938.
254. Larsen CC, Kligman F, Tang C, Kottke-Marchant K, and Marchant RE. 2007. A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion. Biomaterials 28:3537-3548.
255. Ratcliffe A. 2000. Tissue engineering of vascular grafts. Matix Biol. 19:353-357.
256. Nillsen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, and van Kuppevelt TH. 2006. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF.J. Control Release 116: e88-e90.
257. Chang Y, Lai PH, Wei HJ, Lin WW, Chen CH, Hwang SM, et al. 2007. Tissue regeneration observed in a basic fibroblast growth factor-loaded porous acellular bovine pericardium populated with mesenchymal stem cells. J. Thorac. Cardiovasc. Surg. 134:65-73.e1-4.
258. Cushing MC, Liao JT, Jaeggli MP, and Anseth KS. 2007. Material-based regulation of the myofibroblast phenotype. Biomaterials 28:3378-3387.
259. Walluscheck KP, Steinhoff G, Kelm S, and Haverich A. 1996. Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur. J. Vasc. Endovasc. Surg. 12:321-330.
260. Lin HB, Garcia-Echeverria C, Asakura S, Sun W, Mosher DF, and Cooper SL. 1992. Endothelial cell adhesion on polyurethanes containing covalently attached RGD-peptides. Biomaterials 13:905-914.
261. Lin Y-S, Wang S-S, Chung T-W, Wang Y-H, Chiou S-H, Jen-Ji H, et al. 2001. Growth of endothelial cells on different concentrations of Gly-Arg-Gly-Asp photo-chemically grafted in polyethylene glycol modified polyurethane. Artif. Organs 25:617-621.
262. Guan J, Stankus JJ, and Wagner WR. 2007. Biodegradable elastomeric scaffolds with basic fibroblast growth factor release. J. Control Release 120:70-78.
263. Dee KC, Anderson TT, and Bizios R. 1994. Cell function on substrates containing immobilized bioactive peptides. Mar. Res. Soc. Symp. Proc. 331:115-119.
264. Moon JJ, Lee SH, and West JL. 2007. Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules 8:42-49.
265. Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, and Langer R. 2007. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28:2706-2717.
266. Market Dynamics: Bone Substitutes and Growth Factors. 2002. Datamonitor.
267. Sofia S, McCarthy MB, Gronowicz G, and Kaplan DL. 2001. Functionalized silk-based biomaterials for bone formation, J. Biomed. Mater. Res 54:139-148.
268. Chen J, Altman GH, Karageorgiou V, Horan R, Collette A, and Volloch V.2003. Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers, J. Biomed. Mater. Res. A. 67:559-570.
269. Jo S, Engel PS, and Mikos AG. 2000. Synthesis of poly(ethylene glycol)-tethered poly(propylene fumarate) and its modification with GRGD peptides. Polymer 41:7595-7604.
270. Karageorgiou V, Meinel L, Hofmann S, Malhotra A, Volloch V, and Kaplan D. 2004. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells, J. Biomed. Mater. Res. A 71:528-537.
271. Kardestuncer T, McCarthy MB, Karageorgiou V, Kaplan D, and Gronowicz G. 2006. RGD-tethered silk substrate stimulates the differentiation of human tendon cells. Clin. Orthop. Relat. Res. 448:234-239.
272. Chen J, Altman GH, Karageorgiou V, Horan R, Collette A, Volloch V, et al. 2003. Human bone marrow stromal cell and ligament fibroblast responses on RGD-modified silk fibers. J. Biomed. Mater. Res. A. 67:559-570.
273. Jeschke B, Meyer J, Jonczyk A, Kessler H, Adamietz P, Meenen NM, et al. 2002. RGD-peptides for tissue engineering of articular cartilage. Biomaterials 23:3455-3463.
274. Hwang NS, Varghese S, Zhang Z, and Elisseeff J. 2006. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate-modified hydrogels. Tissue Eng. 12:2695-2706.
275. Hsu SH, Chang SH, Yen HJ, Whu SW, Tsai CL, and Chen DC. 2006. Evaluation of biodegradable polyesters modified by type II collagen and Arg-Gly-Asp as tissue engineering scaffolding materials for cartilage regeneration. Artif. Organs 30:42-55.
276. Hsu SH, Whu SW, Hsieh SC, Tsai CL, Chen DC, and Tan TS. 2004. Evaluation of chitosan-alginatehyaluronate complexes modified by an RGD-containing protein as tissue-engineering scaffolds for cartilage regeneration. Artif. Organs 28:693-703.
277. Meinel L, Hofmann S, Karageorgiou V, Zichner L, Langer R, Kaplan D, et al. 2004. Engineering cartilage-like tissue using human mesenchymal stem cells and silk protein scaffolds. Biotechnol. Bioeng. 88:379-391.
278. Hudson T, Evans G, and Schmidt C. 2003. Engineering strategies for peripheral nerve repair. Orthop. Clin. North Am. 31:485-498.
279. Yang F, Murugan R, Ramakrishna S, Wang X, Ma Y-X, and Wang S. 2004. Fabrication of nanostructured porous PLLA scaffold intended for nerve tissue engineering. Biomaterials 25:1891-1900.
280. Park H, Cannizzaro C, Vunjak-Novakovic G, Langer R, Vacanti CA, and Farokhzad OC. 2007. Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng. 13:1867-1877.
281. Dai W, Belt J, and Saltzman WM. 1994. Cell-binding peptides conjugated to poly(ethylene glycol) promote neural cell aggregation. Biotechnology 12:797-801.
282. Borkenhgen M, Clemence J-F, Sigrist H, and Aebischer P. 1999. Three dimensional extracellular matrix engineering in the nervous system. J. Biomed. Mater. Res 40:392-400.
283. Bellamkonda R, Ranieri JP, and Aebischer P. 1995. Laminin oligopeptide derivatized agarose gels allow three dimensional neurite extension in vitro. J. Neurosci. Res. 41:501-509.
284. Ranieri JP, Bellamkonda R, Bekos EJ, Vargo TG, Gardella JA Jr, and Aebischer P. 1995. Neuronal cell attachment to fluorinated ethylene propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. II.J. Biomed. Mater. Res. 29:779-785.
285. Ranieri JP, Bellamkonda R, Bekos EJ, Gardella JA Jr, Mathieu HJ, Ruiz L, et al. 1994. Spatial control of neuronal cell attachment and differentiation on covalently patterned laminin oligopeptide substrates. Int. J. Dev. Neurosci. 12:725-735.
286. Yu TT and Shoichet MS. 2005. Guided cell adhesion and outgrowth in peptide-modified channels for neural tissue engineering. Biomaterials 26:1507.
287. Schense JC, Bloch J, Aebischer P, and Hubbell JA. 2000. Enzymatic incorporation of bioactive peptides into fibrin matrices enhances neurite extension. Nature Biotech. 18:415-419.
288. Collier JH, Camp JP, Hudson TW, and Schmidt CE. 2000. Synthesis and characterization of polypyrrolehyaluronic acid composite biomaterials for tissue engineering applications. J. Biomed. Mater. Res. 50:574-584.
289. Cui X, Lee VA, Raphael Y, Wiler JA, Hetke JF, and Anderson DJ. 2001. Surface modification of neural recording electrodes with conducting polymer/biomolecule blends. J. Biomed. Mater. Res. 56:261-272.
290. Cui X, Wiler J, Dzaman M, Altschuler RA, and Martin DC. 2003. In vivo studies of polypyrrole/peptide coated neural probes. Biomaterials 24:777-787.
291. Stauffer WR and Cui XT. 2006. Polypyrrole doped with 2 peptide sequences from laminin. Biomaterials 27:2405-2413.
292. Marchand-Brynaert J, Detrait E, Noiset O, Boxus T, Schneider YJ, and Remacle C. 1999. Biological evaluation of RGD peptidomimetics, designed for the covalent derivatization of cell culture substrata, as potential promoters of cellular adhesion. Biomaterials 20:1773-1782.
293. Yamaoka T, Hotta Y, Kobayashi K, and Kimura Y. 1999. Synthesis and properties of malic acidcontaining functional polymers. Int. J. Biol. Macromol. 25:265-271.
294. Eid K, Chen E, Griffith L, and Glowacki J. Effect of RGD coating on osteocompatibility of PLGApolymer disks in a rat tibial wound. 2001. J. Biomed. Mater. Res. 57:224-231.
295. Kao WJ and Lee D. 2001. In vivo modulation of host response and macrophage behavior by polymer networks grafted with fibronectin-derived biomimetic oligopeptides: The role of RGD and PHSRN domains. Biomaterials 22:2901-2909.
296. Liu Y and Kao WJ. 2002. Human macrophage adhesion on fibronectin. The role of substratum and intracellular signaling kinases. Cell Signal. 14:145-152.
297. Kao WJ and Liu Y. 2001. Utilizing biomimetic oligopeptides to probe fibronectin-integrin binding and signaling in regulating macrophage function in vitro and in vivo. Front. Biosci. 6:D992-D999.
298. Kao WJ and Liu Y. 2002. Intracellular signaling involved in macrophage adhesion and FBGC formation as mediated by ligand-substrate interaction. J. Biomed. Mater. Res. 62:478-487.
299. Cook AD, Hrkach JS, Gao NN, Johnson IM, Pajvani UB, Cannizzaro SM, et al. 1997. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J. Biomed. Mater. Res. 35:513-523.
300. Barrera DA, Zylstra E, Lansbury PT, and Langer R. 1993. Synthesis and RGD peptide modification of a new biodegradable copolymer poly(lactic acid-co-lysine). J. Am. Chem. Soc. 115:11010-11011.
301. McConachie A, Newman D, Tucci M, Puchett A, Tsao A, Hughs J, et al. 1999. The effect on bioadhesive polymers either freely in solution or covalently attached to a support on human macrophages. Biomed. Sci. Instrum. 35:45-50.
302. Gumusderelioglu M and Turkoglu H. 2002. Biomodification of non-woven polyester fabrics by insulin and RGD for use in serum-free cultivation of tissue cells. Biomaterials 23:3927-3935.
303. Krijgsman B, Seifalian AM, Salacinski HJ, Tai NR, Punshon G, Fuller BJ, et al. 2002. An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: Its role in enhancing cellular retention. Tissue Eng. 8:673-680.
304. Yanagi M, Kishida A, Shimotakahara T, Matsumoto H, Nishijima H, Akashi M, et al. 1994. Experimental study of bioactive polyurethane sponge as an artificial trachea. ASAIO J. 40:M412-M418.
305. Lin HB, Zhao ZC, Garcia-Echeverria C, Rich DH, and Cooper SL. 1992. Synthesis of a novel polyurethane co-polymer containing covalently attached RGD peptide. J. Biomater. Sci. Polym. Ed. 3:217-227.
306. Lin HB, Garcia-Echeverria C, Asakura S, Sun W, Mosher DF, and Cooper SL. 1992. Endothelial cell adhesion on polyurethanes containing covalently attached RGD-peptides. Biomaterials 13:905-914.
307. Anderheiden D, Klee D, Höcker H, Heller B, Kirkpatrick CJ, and Mittermayer C. 1992. Surface modification of a biocompatible polymer based on polyurethane for artificial blood vessels J. Mater. Sci.: Mater. Med. 3:1-4.
308. Johnson R, Harrison D, Tucci M, Tsao A, Lemos M, Puckett A, et al. 1997. Fibrous capsule formation in response to ultrahigh molecular weight polyethylene treated with peptides that influence adhesion. Biomed. Sci. Instrum. 34:47-52.
309. Kugo K, Okuno M, Masuda K, Nishino J, Masuda H, and Iwatsuki M. 1994. Fibroblast attachment to Arg-Gly Asp peptide-immobilized poly(g-methyl l-glutamate). J. Biomater. Sci. Polym. Ed. 5: 325-337.
310. Sanchez M, Deffieux A, Bordenave L, Borquey C, and Fontanille M. 1994. Synthesis of hemocompatible materials. Part 1: Surface modification of polyurethanes based on poly(chloroalkylvinylether)s by RGD fragments. Clin. Mater. 15:253-258.
311. Schaffner P, Meyer J, Dard M, Wenz R, Nies B, Verrier S, et al. 1999. Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies. J. Mater. Sci. Mater. Med. 10:837-839.
312. Irvine DJ, Mayes AM, and Griffith LG. 2001. Nanoscale clustering of RGD peptides at surfaces using Comb polymers. 1. Synthesis and characterization of Comb thin films. Biomacromolecules. 2:85-94.
313. Irvine DJ, Ruzette A-VG, Mayes AM, and Griffith LG. 2001. Nanoscale clustering of RGD peptides at surfaces using comb polymers-2. Surface segregation of comb polymers in polylactide. Biomacromolecules 2:545-556.
314. Koo LY, Irvine DJ, Mayes AM, Lauffenburger DA, and Griffith LG. 2002. Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus. J. Cell Sci. 115:1423-1433.
315. Kondoh A, Makino K, and Matsuda T. 1993. 2-Dimentiona artificial extracellular-matrix bioadhesive peptide immobilized surface design. J. Appl. Polym. Sci. 47:1983-1988.
316. Kobayashi H and Ikada Y. 1991. Corneal cell adhesion and proliferation on hydrogel sheets bound with cell-adhesive proteins. Curr. Eye Res. 10:899-908.
317. Beer JH, Springer KT, and Coller BS. 1992. Immobilized Arg-Gly Asp (RGD) peptides of varying lengths as structural probes of the platelet glycoprotein IIb/IIIa receptor. Blood 79:117-128.
318. Holland J, Hersh L, Bryhan M, Onyiriuka E, and Ziegler L. 1996. Culture of human vascular endothelial cells on an RGD-containing synthetic peptide attached to a starch-coated polystyrene surface: Comparison with fibronectin-coated tissue grade polystyrene. Biomaterials 17:2147-2156.
319. De Giglio E, Sabbatini L, Colucci S, and Zambonin G. 2000. Synthesis, analytical characterization, and osteoblast adhesion properties on RGD-grafted polypyrrole coatings on titanium substrates. J. Biomater. Sci. Polym. Ed. 11:1073-1083.
320. Kam L, Shain W, Turner JN, and Bizios R. 2002. Selective adhesion of astrocytes to surfaces modified with immobilized peptides. Biomaterials 23:511-515.
321. Hasenbein ME, Andersen TT, and Bizios R. 2002. Micropatterned surfaces modified with select peptides promote exclusive interactions with osteoblasts. Biomaterials 23:3937-3942.
322. Ranieri JP, Bellamkonda R, Bekos EJ, Vargo TG Jr, and Aebischer JAG. 1995. Neuronal cell attachment to fluorinated ethylene propylene films with covalently immobilized laminin oligopeptides YIGSR and IKVAV. II.J. Biomed. Mater. Res. 40:371-377.
323. Mineur P, Guignandon A, Lambert ChA, Amblard M, Lapière ChM, and Nusgens BV. 2005. RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblasts. Biochim. Biophys. Acta. 1746:28-37.
324. Harbers GM and Healy KE. 2005. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J. Biomed. Mater. Res. A. 75:855-869.
325. Graham KL, Zeng W, Takada Y, Jackson DC, and Coulson BS. 2004. Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing alpha2beta1 and alphaxbeta2 integrin ligand sequences. J. Virol. 78:11786-11797.
326. Mizuno M and Kuboki Y. 2001. Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J. Biochem. (Tokyo). 129:133-138.